143 related articles for article (PubMed ID: 28570837)
1. High-Throughput Screening and Analysis of Charge Variants of Monoclonal Antibodies in Multiple Formulations.
Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
SLAS Discov; 2017 Sep; 22(8):1044-1052. PubMed ID: 28570837
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
[TBL] [Abstract][Full Text] [Related]
3. Titer and charge-based heterogeneity multiattribute monitoring of mAbs in cell culture harvest using 2D ProA CEX MS.
Sarin D; Kumar S; Rathore AS
Talanta; 2024 Aug; 276():126232. PubMed ID: 38749159
[TBL] [Abstract][Full Text] [Related]
4. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.
Gibson TJ; Mccarty K; Mcfadyen IJ; Cash E; Dalmonte P; Hinds KD; Dinerman AA; Alvarez JC; Volkin DB
J Pharm Sci; 2011 Mar; 100(3):1009-21. PubMed ID: 21280052
[TBL] [Abstract][Full Text] [Related]
5. Formulation development of antibodies using robotic system and high-throughput laboratory (HTL).
Zhao H; Graf O; Milovic N; Luan X; Bluemel M; Smolny M; Forrer K
J Pharm Sci; 2010 May; 99(5):2279-94. PubMed ID: 20014026
[TBL] [Abstract][Full Text] [Related]
6. Hyphenation of strong cation exchange chromatography to native mass spectrometry for high throughput online characterization of charge heterogeneity of therapeutic monoclonal antibodies.
Ma F; Raoufi F; Bailly MA; Fayadat-Dilman L; Tomazela D
MAbs; 2020; 12(1):1763762. PubMed ID: 32370592
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput UPLC method for the characterization of chemical modifications in monoclonal antibody molecules.
Stackhouse N; Miller AK; Gadgil HS
J Pharm Sci; 2011 Dec; 100(12):5115-25. PubMed ID: 21789770
[TBL] [Abstract][Full Text] [Related]
8. Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools.
Razinkov VI; Treuheit MJ; Becker GW
J Biomol Screen; 2015 Apr; 20(4):468-83. PubMed ID: 25576149
[TBL] [Abstract][Full Text] [Related]
9. Capillary ion-exchange chromatography with nanogram sensitivity for the analysis of monoclonal antibodies.
Rea JC; Freistadt BS; McDonald D; Farnan D; Wang YJ
J Chromatogr A; 2015 Dec; 1424():77-85. PubMed ID: 26596872
[TBL] [Abstract][Full Text] [Related]
10. Hydrophobic property of cation-exchange resins affects monoclonal antibody aggregation.
Huang C; Wang Y; Xu X; Mills J; Jin W; Ghose S; Li ZJ
J Chromatogr A; 2020 Nov; 1631():461573. PubMed ID: 33010710
[TBL] [Abstract][Full Text] [Related]
11. Rapid charge variant analysis of monoclonal antibodies to support lead candidate biopharmaceutical development.
Trappe A; Füssl F; Carillo S; Zaborowska I; Meleady P; Bones J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1095():166-176. PubMed ID: 30077097
[TBL] [Abstract][Full Text] [Related]
12. High-throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations.
He F; Woods CE; Becker GW; Narhi LO; Razinkov VI
J Pharm Sci; 2011 Dec; 100(12):5126-41. PubMed ID: 21789772
[TBL] [Abstract][Full Text] [Related]
13. Multi-column displacement chromatography for separation of charge variants of monoclonal antibodies.
Khanal O; Kumar V; Westerberg K; Schlegel F; Lenhoff AM
J Chromatogr A; 2019 Feb; 1586():40-51. PubMed ID: 30573313
[TBL] [Abstract][Full Text] [Related]
14. Screening of monoclonal antibody formulations based on high-throughput thermostability and viscosity measurements: design of experiment and statistical analysis.
He F; Woods CE; Trilisky E; Bower KM; Litowski JR; Kerwin BA; Becker GW; Narhi LO; Razinkov VI
J Pharm Sci; 2011 Apr; 100(4):1330-40. PubMed ID: 24081468
[TBL] [Abstract][Full Text] [Related]
15. Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part I: salt gradient approach.
Fekete S; Beck A; Fekete J; Guillarme D
J Pharm Biomed Anal; 2015 Jan; 102():33-44. PubMed ID: 25240157
[TBL] [Abstract][Full Text] [Related]
16. Development of a high-throughput solubility screening assay for use in antibody discovery.
Chai Q; Shih J; Weldon C; Phan S; Jones BE
MAbs; 2019; 11(4):747-756. PubMed ID: 30913963
[TBL] [Abstract][Full Text] [Related]
17. High-throughput multiplex analysis of mAb aggregates and charge variants by automated two-dimensional size exclusion-cation exchange chromatography coupled to mass spectrometry.
Lambiase G; Inman SE; Muroni M; Lindo V; Dickman MJ; James DC
J Chromatogr A; 2022 May; 1670():462944. PubMed ID: 35344792
[TBL] [Abstract][Full Text] [Related]
18. Double-peak elution profile of a monoclonal antibody in cation exchange chromatography is caused by histidine-protonation-based charge variants.
Luo H; Cao M; Newell K; Afdahl C; Wang J; Wang WK; Li Y
J Chromatogr A; 2015 Dec; 1424():92-101. PubMed ID: 26596869
[TBL] [Abstract][Full Text] [Related]
19. Charge heterogeneity profiling of monoclonal antibodies using low ionic strength ion-exchange chromatography and well-controlled pH gradients on monolithic columns.
Talebi M; Nordborg A; Gaspar A; Lacher NA; Wang Q; He XZ; Haddad PR; Hilder EF
J Chromatogr A; 2013 Nov; 1317():148-54. PubMed ID: 24011724
[TBL] [Abstract][Full Text] [Related]
20. Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysis.
Shi RL; Xiao G; Dillon TM; Ricci MS; Bondarenko PV
MAbs; 2020; 12(1):1739825. PubMed ID: 32292112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
